EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Global challenges in diabetes research and care: which way forward? An appraisal from the EASD Global Council

Francesco Giorgino, Fawaz Alzaid, Anca Pantea Stoian, Juliana C N Chan, Linong Ji, William Lumu, Helard Manrique, Didac Mauricio, Banshi Saboo, Peter A Senior, Daisuke Yabe, Sophia Zoungas und 3 weitere

Diabetologia · 2025-11 · 68 (11) · 2479-2498

DOI: 10.1007/s00125-025-06504-5 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Diabetologia, online erschienen am 10.09.2025. Verfasst von Francesco Giorgino und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Precision and Regenerative Medicine and Ionian Area, Section of Internal Medicine, Endocrinology, Andrology and Metabolic Diseases, Uni…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Biomedical Research. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 132 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This review article, developed by the EASD Global Council, addresses the growing global challenges in diabetes research and care, highlighting the rising prevalence of diabetes, the increasing complexity of its management and the need for a coordinated international response. With regard to research, disparities in funding and infrastructure between high-income countries and low- and middle-income countries (LMICs) are discussed. The under-representation of LMIC populations in clinical trials, challenges in conducting large-scale research projects, and the ethical and legal complexities of artificial intelligence integration are also considered as specific issues. The development of global research networks and strategies for improved training, standardisation of data and enhanced accessibility to big data analytics to drive innovation and personalised medicine are recommended. With regard to diabetes care, inequalities in access to essential medications, particularly insulin and novel therapies, and disparities in healthcare infrastructure are discussed. Proposed initiatives include international support programmes, improved healthcare provider training and the inclusion of newer diabetes medications in essential drug lists. The importance of global screening programmes, a universal diabetes education curriculum and standardised healthcare checklists is also emphasised. Regarding healthcare organisation, the development of national diabetes registers, benchmarking performance across regions and strengthening international collaborations are highly advised. The role of diabetes specialists as care coordinators and the need for structured assessments to improve early intervention and long-term outcomes are also discussed. Ultimately, the EASD Global Council urges action for a unified, global approach to diabetes research and care to bridge the gap between scientific innovation and clinical practice, ensuring equitable healthcare worldwide.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes MellitusBiomedical ResearchHumansGlobal Health

Stichwörter der Autor:innen

Artificial intelligenceBig dataClinical trialsDiabetesDiabetes registersDigital healthEducation and trainingEquity, diversity and inclusionHealth systemsLow- and middle-income countriesPersonalised medicineReview

Autor:innen und Institutionen

  • Department of Precision and Regenerative Medicine and Ionian Area, Section of Internal Medicine, Endocrinology, Andrology and Metabolic Diseases, University of Bari Aldo Moro, Bari, Italy. francesco.giorgino@uniba.it.
  • Dasman Diabetes Institute, Kuwait City, Kuwait.
  • Institut Necker-Enfants Malades, Inserm U1151, CNRS UMR 8253, IMMEDIAB Laboratory, Paris, France.
  • Diabetes, Nutrition and Metabolic Diseases Department, 'Carol Davila' University of Medicine and Pharmacy, Bucharest, Romania.
  • Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong, HKSAR, China.
  • Hong Kong Institute of Diabetes and Obesity, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong, HKSAR, China.

Zitieren

APA

Giorgino, F., Alzaid, F., Pantea Stoian, A., Chan, J. C. N., Ji, L., Lumu, W., Manrique, H., Mauricio, D., Saboo, B., Senior, P. A., Yabe, D., Zoungas, S., Meireles, M., Mathieu, C., & Czupryniak, L. (2025). Global challenges in diabetes research and care: which way forward? An appraisal from the EASD Global Council. Diabetologia, 68(11), 2479-2498. https://doi.org/10.1007/s00125-025-06504-5

Vancouver

Giorgino F, Alzaid F, Pantea Stoian A, Chan JCN, Ji L, Lumu W, et al. Global challenges in diabetes research and care: which way forward? An appraisal from the EASD Global Council. Diabetologia. 2025;68(11):2479-2498. doi:10.1007/s00125-025-06504-5

BibTeX
@article{Giorgino2025,
  author = {Giorgino, Francesco and Alzaid, Fawaz and Pantea Stoian, Anca and Chan, Juliana C N and Ji, Linong and Lumu, William and Manrique, Helard and Mauricio, Didac and Saboo, Banshi and Senior, Peter A and Yabe, Daisuke and Zoungas, Sophia and Meireles, Manuela and Mathieu, Chantal and Czupryniak, Leszek},
  title = {Global challenges in diabetes research and care: which way forward? An appraisal from the EASD Global Council},
  journal = {Diabetologia},
  year = {2025},
  volume = {68},
  number = {11},
  pages = {2479--2498},
  doi = {10.1007/s00125-025-06504-5}
}
Kostenlos starten →